Atraverse Medical
Chicago, US · Founded 2022 · Delaware corporation · 36 employees on LinkedIn · 2 known investors
Find your way into Atraverse Medical
Each arrow is one introduction. Sign up to fill in the first one.
Ask Michael Wiley to introduce you to Steven Mickelsen
You →Michael · together at FARAPULSE, Inc. →Steven
Ask Jamie Chen to introduce you to John R Slump
You →Jamie · together at FARAPULSE, Inc. →John
Sign up to find every way you can get introduced to Atraverse Medical
- Your email: who you already know at Atraverse Medical, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Atraverse Medical team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Atraverse Medical develops flexible transseptal access technologies for left-heart catheter procedures, including an RF-guidewire enabled puncture device that supports a Zero Exchange workflow. Its products are aimed at physicians performing catheter-based cardiac interventions.
Founders & leadership
Atraverse Medical was founded in 2022 by Steven Mickelsen.


Board
Investors · 2
Reported raises · per SEC filings
Form D private placements$33.1M disclosed across 5 rounds · 2023–2025
▶$8.6MraisedMay 2025 · 41 investors · Other Health CareRule 506(b)
- Eric D. SauterExecutive Officer, Director, Promoter
- John R. SlumpExecutive Officer, Director, Promoter
- Steven MickelsenExecutive Officer, Director, Promoter
- Offering amount
- $10M
- Amount sold
- $8.6M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$15MraisedFeb 2025 · 1 investors · Other Health CareRule 506(b)
- Eric D. SauterExecutive Officer, Director, Promoter
- John R SlumpExecutive Officer, Director, Promoter
- Steven R. MickelsenExecutive Officer, Director, Promoter
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$4.1MraisedAug 2024 · 33 investors · Other Health CareRule 506(b)
- Eric SauterDirector
- Steven MickelsenDirector
- John R SlumpExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $4.1M
- Minimum investment
- $10K
- Proceeds to insiders
- $750K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$5MraisedNov 2023 · 32 investors · Other Health CareRule 506(b)
- Eric SauterDirector
- John R SlumpExecutive Officer, Director
- Steven MickelsenDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $100K
- Proceeds to insiders
- $1M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$400KraisedNov 2023 · 1 investors · Other Health CareRule 506(b)
- John R SlumpExecutive Officer, Director
- Eric SauterDirector
- Steven MickelsenDirector
- Offering amount
- $3M
- Amount sold
- $400K
- Minimum investment
- $100K
- Proceeds to insiders
- $500K
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Atraverse Medical went on to found or lead other companies.
In the news
Frequently asked questions
- What does Atraverse Medical do?
- Atraverse Medical develops flexible transseptal access technologies for left-heart catheter procedures, including an RF-guidewire enabled puncture device that supports a Zero Exchange workflow. Its products are aimed at physicians performing catheter-based cardiac interventions.
- Who founded Atraverse Medical?
- Atraverse Medical was founded by Steven Mickelsen in 2022.
- Who are Atraverse Medical's investors?
- Atraverse Medical's investors include Band of Angels, MEDA Angels.
- How much funding has Atraverse Medical raised?
- Atraverse Medical has disclosed $33.1M raised across 5 rounds.
- Where is Atraverse Medical headquartered?
- Atraverse Medical is headquartered in Chicago, US.

